HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Carl S Hornfeldt Selected Research

Sodium Oxybate (gamma Hydroxybutyrate)

12/2010The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
9/2009The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
4/2009Exacerbation of cataplexy following gradual withdrawal of antidepressants: manifestation of probable protracted rebound cataplexy.
1/2006The clinical development of gamma-hydroxybutyrate (GHB).
1/2004The Xyrem risk management program.
9/2003From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy.
6/2002Sodium oxybate (GHB) for treatment of cataplexy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Carl S Hornfeldt Research Topics

Disease

7Cataplexy
12/2010 - 06/2002
6Narcolepsy
12/2010 - 09/2003
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
07/2010

Drug/Important Bio-Agent (IBA)

7Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
12/2010 - 06/2002
1Fluvoxamine (Luvox)FDA LinkGeneric
07/2010
1modafinil (armodafinil)FDA Link
09/2009
1Antidepressive Agents (Antidepressants)IBA
04/2009